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Entecavir is a synthetic guanosine nucleoside that plays an important role in treatment of 
chronical hepatitis B virus infection. This work was focused on development of highly 
sensitive method to determine entecavir concentrations in rat urine by ultra-high performance 




, stable isotopically 
labeled internal standard, was used for quantitation. Hydrophilic interaction chromatography 
seems to be a suitable technique for retention and separation of polar compounds present in 
analyzed sample. One of the main goals was to confirm this fact by comparison with 
commonly used reverse phase chromatography mode (RP-UHPLC) on BEH C18 stationary 
phase. Conditions for RP-UHPLC were optimized as follows: mobile phase composed of 
acetonitrile/0.01 % formic acid (4:96).  The HILIC conditions on  BEH Amide stationary 
phase were optimized using isocratic elution with mobile phase composed of acetonitrile/5 
mM ammonium acetate  pH 4.0 (75:25). HILIC method provided much better results in terms 
of linearity and repeatability. Due to high polarity of entecavir Oasis HLB cartridge was 
chosen for solid phase extraction. Advantageously entecavir was eluted with 75 % acetonitrile 
in water, which was the same composition as HILIC mobile phase. Therefore, evaporation 
step could be omitted. Several strategies were used to overcome matrix effect, such as 
UHPLC separation, HILIC chromatography, SPE sample pre-treatment, stable isotopically 
labeled internal standard and dilution step. Therefore, influence of matrix effects, which were 
determined by post-column infusion and post-extraction addition method, was negligible in 
this method. The following validation parameters demonstrated the suitability of this method 
for the determination of entecavir in rat urine – accuracy (< 5% error), recovery (87 – 109 %), 
precision (< 3% RSD), selectivity and sensitivity (LOQ = 100 pg/ml). 
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